TrialTrials2021

IMI2-PainCare-BioPain-RCT3: a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by electroencephalography (EEG).

André Mouraux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.